Works matching DE "FINGOLIMOD"

Results: 665

Effectiveness and Safety Profile of Fingolimod in Treating Omani Patients with Multiple Sclerosis: A single tertiary centre experience.

Published in:

Sultan Qaboos University Medical Journal, 2025, v. 25, n. 1, p. 225, doi. 10.18295/2075-0528.2829

By:

Al-Hashmi, Ghaida K. H.;
Al-Asmi, Abdullah;
Islam, M. Mazharul;
Al-Zakwani, Ibrahim;
Butt, Mehwish;
Al-Qassabi, Ahmed;
Al-Abri, Haifa;
Gujjar, Arunodaya R.

Publication type:

Article

Safety and effectiveness of fingolimod in Japanese patients with multiple sclerosis: Results of a post‐marketing surveillance study.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 2, p. 118, doi. 10.1111/cen3.12814

By:

Sato, Noriko;
Wakimoto, Koji;
Kato, Kyoko;
Susuta, Yutaka;
Ueda, Kengo;
Satou, Yoshihisa;
Sasajima, Takayoshi;
Kira, Jun‐ichi

Publication type:

Article

Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsy.

Published in:

Indian Journal of Pharmacology, 2023, v. 55, n. 5, p. 307, doi. 10.4103/ijp.ijp_100_23

By:

Garg, Nitika;
Joshi, Rupa;
Bhatia, Alka;
Bansal, Seema;
Chakrabarti, Amitava;
Prakash, Ajay;
Saikia, Biman;
Modi, Manish;
Medhi, Bikash

Publication type:

Article

Are different degrees of lymphopenia for FTY720 associated with serious infectious-type events? No.

Published in:

Revista Mexicana de Neurociencia, 2022, v. 23, n. 3, p. 92, doi. 10.24875/RMN.21000048

By:

Márquez-Martín, Catalina;
García-Bermúdez, Ricardo J.;
Bertado-Cortés, Brenda

Publication type:

Article

Fingolimod hydrochloride gel shows promising therapeutic effects in a mouse model of atopic dermatitis.

Published in:

Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 10, p. 1268, doi. 10.1111/jphp.12588

By:

Tamakuwala, Mayurkumar;
Ratna, Warren;
Joshi, Amit;
Stagni, Grazia

Publication type:

Article

Risk of T<sub>2</sub> lesions when discontinuing fingolimod: a nationwide predictive and comparative study.

Published in:

Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcad358

By:

Wandall-Holm, Malthe Faurschou;
Holm, Rolf Pringler;
Heick, Alex;
Langkilde, Annika Reynberg;
Magyari, Melinda

Publication type:

Article

Immunohistochemical analysis of protective effects of maternal fingolimod on the placenta and fetal lung and brain in chorioamnionitis-induced preterm birth rat model.

Published in:

Immunopharmacology & Immunotoxicology, 2020, v. 42, n. 6, p. 564, doi. 10.1080/08923973.2020.1818771

By:

Yavuz, And;
Sezik, Mekin;
Eris Yalcin, Serenat;
Asci, Halil;
Ozmen, Ozlem

Publication type:

Article

Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).

Published in:

Turkish Journal of Medical Sciences, 2023, v. 53, n. 1, p. 323, doi. 10.55730/1300-0144.5588

By:

TUNCER, Aslı;
KÜRTÜNCÜ, Murat;
TERZİ, Murat;
UYGUNOĞLU, Uğur;
GÖNCÜOĞLU, Cansu;
YÜCEYAR, Ayşe Nur;
EKMEKÇİ, Özgül;
TÜRKOĞLU, Recai;
SOYSAL, Aysun;
KÖSEOĞLU, Mesrure;
BOZ, Cavit;
BECKMANN, Yeşim;
TURAN, Ömer Faruk;
DEMİRKIRAN, Meltem;
AKMAN, Gülşen;
ALTUNRENDE, Burcu;
AYDIN CANTÜRK, İlknur;
BİRDAY, Erkingül;
ÖZCAN, Abdulcemal;
KAMIŞLI, Özden

Publication type:

Article

Design, Synthesis, Bioactivity Analyses, and Molecular Docking Study of Triazine-Tyrosine Based Derivatives as Drugs like Fingolimod for Treatment of Multiple Sclerosis.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 4, p. 2292, doi. 10.1080/10406638.2023.2215375

By:

Asadi, Parvin;
Khodarahmi, Ghadamali;
Rafiee, Amin;
Aliomrani, Mehdi;
Hassanzadeh, Farshid

Publication type:

Article

Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.

Published in:

Central European Journal of Immunology, 2015, v. 40, n. 3, p. 354, doi. 10.5114/ceji.2015.54599

By:

RUDNICKA, JULIA;
CZERWIEC, MICHAŁ;
GRYWALSKA, EWELINA;
SIWICKA-GIEROBA, DOROTA;
WALANKIEWICZ, MONIKA;
GRAFKA, AGNIESZKA;
ZGURSKI, MICHAŁ;
SURDACKA, AGATA;
BARTOSIK-PSUJEK, HALINA;
ROLIŃSKI, JACEK

Publication type:

Article

Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL).

Published in:

Journal of Intensive Care, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40560-019-0376-2

By:

Winkler, Martin Sebastian;
Märtz, Konstantin B.;
Nierhaus, Axel;
Daum, Günter;
Schwedhelm, Edzard;
Kluge, Stefan;
Gräler, Markus H.

Publication type:

Article

Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose-6-phosphate isomerase peptide-induced arthritis.

Published in:

Immunity, Inflammation & Disease, 2016, v. 4, n. 3, p. 263, doi. 10.1002/iid3.111

By:

Yoshida, Yuya;
Mikami, Norihisa;
Matsushima, Yuki;
Miyawaki, Mai;
Endo, Hiroki;
Banno, Rie;
Tsuji, Takumi;
Fujita, Tetsuro;
Kohno, Takeyuki

Publication type:

Article

Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.

Published in:

Experimental Dermatology, 2017, v. 26, n. 3, p. 206, doi. 10.1111/exd.13174

By:

Thieme, Markus;
Zillikens, Detlef;
Sadik, Christian D.

Publication type:

Article

A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumab.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 1, p. e100, doi. 10.1111/ajd.13983

By:

Megna, Matteo;
Noto, Matteo;
Fabbrocini, Gabriella;
Fornaro, Luigi

Publication type:

Article

Papaverine Derivatives, a Potent Inhibitor of Neuroinflammation in Epileptic Seizures, A Pharmacological and In-Silico Approach Against TNF-α as a Targeted Receptor.

Published in:

Journal of the Chemical Society of Pakistan, 2023, v. 45, n. 6, p. 524, doi. 10.52568/001395/jcsp/45.06.2023

By:

Tariq, Zeenia;
Miana, G.A.;
Kanwal, Madiha;
Fahim, Muhammad;
Malik, Sumra

Publication type:

Article

OP11.05: Fingolimod against endotoxin-induced fetal brain injury in the rat model.

Published in:

Ultrasound in Obstetrics & Gynecology, 2016, v. 48, p. 84, doi. 10.1002/uog.16260

By:

Yavuz, A.;
Sezik, M.;
Ozmen, O.;
Asci, H.

Publication type:

Article

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00645

By:

Ahmed, Naseer;
Linardi, Daniele;
Muhammad, Nazeer;
Chiamulera, Cristiano;
Fumagalli, Guido;
Biagio, Livio San;
Gebrie, Mebratu A.;
Aslam, Muhammad;
Luciani, Giovanni Battista;
Faggian, Giuseppe;
Rungatscher, Alessio

Publication type:

Article

Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.

Published in:

Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00412

By:

Ottenlinger, Florian M.;
Mayer, Christoph A.;
Ferreirós, Nerea;
Schreiber, Yannick;
Schwiebs, Anja;
Schmidt, Katrin G.;
Ackermann, Hanns;
Pfeilschifter, Josef M.;
Radeke, Heinfried H.

Publication type:

Article

Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00217

By:

Eken, Ahmet;
Yetkin, Mehmet Fatih;
Vural, Alperen;
Okus, Fatma Zehra;
Erdem, Serife;
Azizoglu, Zehra Busra;
Haliloglu, Yesim;
Cakir, Mustafa;
Turkoglu, Enes Mehmet;
Kilic, Omer;
Kara, Irfan;
Dönmez Altuntaş, Hamiyet;
Oukka, Mohamed;
Kutuk, Mehmet Serdar;
Mirza, Meral;
Canatan, Halit

Publication type:

Article

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02189

By:

Mike, Elise V.;
Makinde, Hadijat M.;
Der, Evan;
Stock, Ariel;
Gulinello, Maria;
Gadhvi, Gaurav T.;
Winter, Deborah R.;
Cuda, Carla M.;
Putterman, Chaim

Publication type:

Article

Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01693

By:

Moreno-Torres, Irene;
González-García, Coral;
Marconi, Marco;
García-Grande, Aranzazu;
Rodríguez-Esparragoza, Luis;
Elvira, Víctor;
Ramil, Elvira;
Campos-Ruíz, Lucía;
García-Hernández, Ruth;
Al-Shahrour, Fátima;
Fustero-Torre, Coral;
Sánchez-Sanz, Alicia;
García-Merino, Antonio;
Sánchez López, Antonio José

Publication type:

Article

Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01560

By:

Lohmann, Lisa;
Janoschka, Claudia;
Schulte-Mecklenbeck, Andreas;
Klinsing, Svenja;
Kirstein, Lucienne;
Hanning, Uta;
Wirth, Timo;
Schneider-Hohendorf, Tilman;
Schwab, Nicholas;
Gross, Catharina C.;
Eveslage, Maria;
Meuth, Sven G.;
Wiendl, Heinz;
Klotz, Luisa

Publication type:

Article

Alteration of neuroinflammation detected by <sup>18</sup>F-GE180 PET imaging in place-conditioned rats with morphine withdrawal.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00849-9

By:

Li, Junpeng;
Shao, Da;
Jiang, Donglang;
Huang, Qi;
Guan, Yihui;
Lai, Bin;
Zhao, Jun;
Hua, Fengchun;
Xie, Fang

Publication type:

Article

Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data.

Published in:

Psychopharmacology, 2022, v. 239, n. 1, p. 1, doi. 10.1007/s00213-021-06011-6

By:

Schoedel, Kerri A.;
Kolly, Carine;
Gardin, Anne;
Neelakantham, Srikanth;
Shakeri-Nejad, Kasra

Publication type:

Article

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 10, p. 1367, doi. 10.1080/03007995.2023.2256220

By:

Butzkueven, Helmut;
Hillert, Jan;
Soilu-Hänninen, Merja;
Ziemssen, Tjalf;
Kuhle, Jens;
Wergeland, Stig;
Magyari, Melinda;
Berger, Joseph R.;
Moore, Nicholas;
Aydemir, Aida;
Bezemer, Irene;
Sabidó, Meritxell

Publication type:

Article

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population.

Published in:

ARYA Atherosclerosis, 2016, v. 12, n. 6, p. 274

By:

Abdar, Morteza;
Ebrahimifar, Payam;
Etemadifar, Masoud

Publication type:

Article

MS medication may be associated with macula edema.

Published in:

Optometry Times, 2014, v. 6, n. 6, p. 19

By:

Ferrucci, Steven;
Shandrick, Alyssa

Publication type:

Article

Real‐life clinical use of natalizumab and fingolimod in Austria.

Published in:

Acta Neurologica Scandinavica, 2018, v. 137, n. 2, p. 181, doi. 10.1111/ane.12864

By:

Guger, M.;
Enzinger, C.;
Leutmezer, F.;
Kraus, J.;
Kalcher, S.;
Kvas, E.;
Berger, T.

Publication type:

Article

Safety concerns and risk management of multiple sclerosis therapies.

Published in:

Acta Neurologica Scandinavica, 2017, v. 136, n. 3, p. 168, doi. 10.1111/ane.12712

By:

Soelberg Sorensen, P.

Publication type:

Article

A longitudinal real-life comparison study of natalizumab and fingolimod.

Published in:

Acta Neurologica Scandinavica, 2017, v. 136, n. 3, p. 217, doi. 10.1111/ane.12718

By:

Lanzillo, R.;
Carotenuto, A.;
Moccia, M.;
Saccà, F.;
Russo, C. V.;
Massarelli, M.;
De Rosa, A.;
Brescia Morra, V.

Publication type:

Article

Early safety and efficacy of fingolimod treatment in Denmark.

Published in:

Acta Neurologica Scandinavica, 2017, v. 135, n. 1, p. 129, doi. 10.1111/ane.12573

By:

Voldsgaard, A.;
Koch‐Henriksen, N.;
Magyari, M.;
Sellebjerg, F.;
Sørensen, P. S.;
Oturai, A. B.

Publication type:

Article

Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.

Published in:

Acta Neurologica Scandinavica, 2015, v. 131, n. 2, p. 140, doi. 10.1111/ane.12357

By:

Signoriello, E.;
Sagliocchi, A.;
Fratta, M.;
Lus, G.

Publication type:

Article

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

Published in:

Acta Neurologica Scandinavica, 2014, v. 129, n. 3, p. e12, doi. 10.1111/ane.12182

By:

Wipfler, P.;
Harrer, A.;
Pilz, G.;
Oppermann, K.;
Afazel, S.;
Haschke‐Becher, E.;
Sellner, J.;
Trinka, E.;
Kraus, J.

Publication type:

Article

Correction: Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.

Published in:

2023

By:

Bonfiglio, Tommaso;
Olivero, Guendalina;
Merega, Elisa;
Di Prisco, Silvia;
Padolecchia, Cristina;
Grilli, Massimo;
Milanese, Marco;
Di Cesare Mannelli, Lorenzo;
Ghelardini, Carla;
Bonanno, Giambattista;
Marchi, Mario;
Pittaluga, Anna

Publication type:

Correction Notice

Ocrelizumab experience in treatment-resistant warts associated with Fingolimod: A case report.

Published in:

Neurology Asia, 2024, v. 29, n. 2, p. 489, doi. 10.54029/2024kps

By:

Uca, Ali Ulvi

Publication type:

Article

FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models.

Published in:

Neurochemical Research, 2017, v. 42, n. 2, p. 686, doi. 10.1007/s11064-016-2125-4

By:

Ren, Manru;
Han, Minxing;
Wei, Xinbing;
Guo, Ying;
Shi, Huanying;
Zhang, Xiumei;
Perez, Ruth;
Lou, Haiyan

Publication type:

Article

Poloxamer-Alginate In-Situ Gel Containing Glatiramer Acetate Intended for Multiple Sclerosis Treatment.

Published in:

International Journal of Multiphysics, 2024, v. 18, n. 4, p. 565

By:

Shobeirean, Anahita;
Attar, Hossein;
Varshochianb, Reyhaneh;
Rezvanfar, Mohammad Amin

Publication type:

Article

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.

Published in:

2018

By:

Tian, De‐Cai;
Shi, Kaibin;
Zhu, Zilong;
Yao, Jia;
Yang, Xiaoxia;
Su, Lei;
Zhang, Sheng;
Zhang, Meixia;
Gonzales, Rayna J.;
Liu, Qiang;
Huang, DeRen;
Waters, Michael F.;
Sheth, Kevin N.;
Ducruet, Andrew F.;
Fu, Ying;
Lou, Min;
Shi, Fu‐Dong;
Tian, De-Cai;
Shi, Fu-Dong

Publication type:

journal article

Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.

Published in:

2018

By:

Cramer, Stig P.;
Simonsen, Helle J.;
Varatharaj, Aravinthan;
Galea, Ian;
Frederiksen, Jette L.;
Larsson, Henrik B. W.

Publication type:

journal article

Clinical studies and anti-inflammatory mechanisms of treatments.

Published in:

Epilepsia (Series 4), 2017, v. 58, p. 69, doi. 10.1111/epi.13779

By:

French, Jacqueline A.;
Koepp, Matthias;
Naegelin, Yvonne;
Vigevano, Federico;
Auvin, Stéphane;
Rho, Jong M.;
Rosenberg, Evan;
Devinsky, Orrin;
Olofsson, Peder S.;
Dichter, Marc A.

Publication type:

Article

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod.

Published in:

Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02811-z

By:

Gonzalez-Martinez, Alicia;
Patel, Rohit;
Healy, Brian C.;
Lokhande, Hrishikesh;
Paul, Anu;
Saxena, Shrishti;
Polgar-Turcsanyi, Mariann;
Weiner, Howard L.;
Chitnis, Tanuja

Publication type:

Article

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.

Published in:

2022

By:

Camacho-Toledano, Celia;
Machín-Díaz, Isabel;
Calahorra, Leticia;
Cabañas-Cotillas, María;
Otaegui, David;
Castillo-Triviño, Tamara;
Villar, Luisa María;
Costa-Frossard, Lucienne;
Comabella, Manuel;
Midaglia, Luciana;
García-Domínguez, José Manuel;
García-Arocha, Jennifer;
Ortega, María Cristina;
Clemente, Diego

Publication type:

journal article

Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.

Published in:

Dermatology Online Journal, 2019, v. 25, n. 9, p. 1, doi. 10.5070/d3259045508

By:

Wills, Abby;
Guang Fan;
Kim, Edward;
Okada, Craig Y.;
White, Kevin P.;
Hopkins, R. Samuel

Publication type:

Article

Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.

Published in:

Biological Chemistry, 2015, v. 396, n. 6/7, p. 795, doi. 10.1515/hsz-2014-0287

By:

Schröder, Matthias;
Arlt, Olga;
Schmidt, Helmut;
Huwiler, Andrea;
Angioni, Carlo;
Pfeilschifter, Josef M.;
Schwiebs, Anja;
Radeke, Heinfried H.

Publication type:

Article

Protective Effect of FTY720 Against Sevoflurane-Induced Developmental Neurotoxicity in Rats.

Published in:

Cell Biochemistry & Biophysics, 2013, v. 67, n. 2, p. 591, doi. 10.1007/s12013-013-9546-3

By:

Zhou, Hui;
Li, Song;
Niu, Xinhuan;
Wang, Ping;
Wang, Junnan;
Zhang, Mengyuan

Publication type:

Article

Determination of synthetic hallucinogens in oral fluids by microextraction by packed sorbent and liquid chromatography–tandem mass spectrometry.

Published in:

Analytical & Bioanalytical Chemistry, 2023, v. 415, n. 17, p. 3607, doi. 10.1007/s00216-023-04751-2

By:

Lesne, Evan;
Muñoz-Bartual, Miguel;
Esteve-Turrillas, Francesc A.

Publication type:

Article

Personalized treatments in neuropsychiatric disorders.

Published in:: Drug Development Research, 2021, v. 82, n. 5, p. 618, doi. 10.1002/ddr.21854
Publication type:: Article

A Pharmacokinetic Study of Ephedrine and Pseudoephedrine after Oral Administration of Ojeok-San by Validated LC-MS/MS Method in Human Plasma.

Published in:

Molecules, 2021, v. 26, n. 22, p. 6991, doi. 10.3390/molecules26226991

By:

Lee, Sooyoung;
Shim, Wang-Seob;
Yoo, Heejo;
Choi, Sanghee;
Yoon, Jiyoung;
Lee, Kwang-Young;
Chung, Eun-Kyoung;
Lee, Byung-Cheol;
Yim, Sung-Vin;
Kim, Bo-Hyung;
Lee, Kyung-Tae

Publication type:

Article

Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism.

Published in:

Molecules, 2021, v. 26, n. 1, p. 5, doi. 10.3390/molecules26010005

By:

Burgos, Rafael Agustín;
Alarcón, Pablo;
Quiroga, John;
Manosalva, Carolina;
Hancke, Juan;
Fabroni, Simona;
Marszałek, Krystian;
Todaro, Aldo

Publication type:

Article

Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes.

Published in:

Molecules, 2020, v. 25, n. 19, p. 4525, doi. 10.3390/molecules25194525

By:

Chang, Wei-Ting;
Liu, Ping-Yen;
Wu, Sheng-Nan

Publication type:

Article